Soft pastels · Free shipping over $75 · Shop the boutique
Login Register
glp-1 drugs alzheimer's

glp-1 drugs alzheimer's Potential Role of Glucagon-like Peptide-1 Receptor Agonists in the Treatment of Cognitive Decline and Dementia in Diabetes Mellitus Blockbuster GLP-1 Diabetes and Weight

SKU: 83620071200

4.6
EUR25.83 EUR68.83

Pay in 4 interest-free payments of $6.46 Learn more

Shipping Estimate
USA
  • USA
  • CAN

Ships within 48 hours · Estimated delivery Aug 18 - Aug 23

Description

Oct 28 2020;7(11)doi:10.3390/medicines7110067 Liu B, Meng X, Ma Y, et al

glp-1 drugs alzheimer's Potential Role of Glucagon-like Peptide-1 Receptor Agonists in the Treatment of Cognitive Decline and Dementia in Diabetes Mellitus Blockbuster GLP-1 Diabetes and Weight

Results The study included 289,809 adults (median age 54.6 years, 65.2% female, 69.2% with type 2 diabetes)

glp-1 drugs alzheimer's Potential Role of Glucagon-like Peptide-1 Receptor Agonists in the Treatment of Cognitive Decline and Dementia in Diabetes Mellitus Blockbuster GLP-1 Diabetes and Weight

Giustarini et al., 2016

glp-1 drugs alzheimer's Potential Role of Glucagon-like Peptide-1 Receptor Agonists in the Treatment of Cognitive Decline and Dementia in Diabetes Mellitus Blockbuster GLP-1 Diabetes and Weight

The new tissue shows better organization and cross-linking, potentially creating stronger repairs than would occur naturally

glp-1 drugs alzheimer's Potential Role of Glucagon-like Peptide-1 Receptor Agonists in the Treatment of Cognitive Decline and Dementia in Diabetes Mellitus Blockbuster GLP-1 Diabetes and Weight
Exchange/Return Notes
  • We offer a 30-day return/exchange service after receiving.
  • Final sale items are not eligible for returns or exchanges.
  • To process your return/exchange, please contact us at [email protected]
  • Please click here for more details>>> Return & Exchange Policy

You may also like

recommand products